Medtronic (MDT) Net Cash Flow Growth (3y) (2017 - 2026)
Medtronic (MDT) Net Cash Flow Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | -32.51% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -87.87% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 42.74% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -11.49% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -87.88% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -48.90% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 129.29% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -65.12% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 33.47% |
| 10 | Zimmer Biomet Holdings | 17.18 Bn | 16.77 Bn | 1.51 Bn | -51.65% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 23, 2026 | 42.74% |
| Oct 24, 2025 | -74.18% |
| Jul 25, 2025 | 11.34% |
| Apr 25, 2025 | 22.40% |
| Jan 24, 2025 | -26.81% |
| Oct 25, 2024 | 41.47% |
| Jul 26, 2024 | 80.59% |
| Apr 26, 2024 | 42.54% |
| Jan 26, 2024 | 29.84% |
| Oct 27, 2023 | 46.71% |
| Jul 28, 2023 | -27.52% |
| Apr 28, 2023 | -97.92% |
| Jan 27, 2023 | -46.93% |
| Oct 28, 2022 | 65.82% |
| Jul 29, 2022 | -60.31% |
| Apr 29, 2022 | -18.42% |
| Jan 28, 2022 | 68.28% |
| Oct 29, 2021 | 40.28% |
| Jul 30, 2021 | -39.39% |
| Apr 30, 2021 | 18.22% |